Single-Photon Emission Computed Tomography (SPECT) Market Size & Growth Forecast 2026–2035, By Segments (Application Channel, End Use Channel, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Single-Photon Emission Computed Tomography Market size was valued at USD 3.97 Billion in 2025 and is anticipated to grow at a 2.9% CAGR from 2026 to 2035, crossing USD 5.28 Billion by 2035. The industry revenue for 2026 is calculated at USD 4.07 billion.
Get more details on this report
Request Free Sample ReportSingle-Photon Emission Computed Tomography (SPECT) Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 46.56% share due to strong nuclear imaging infrastructure, widespread clinical use in cardiology and oncology, and established hospital-based diagnostic workflows.
- Asia Pacific is growing at 3.31% CAGR as healthcare systems expand imaging access, invest in diagnostic capacity, and gradually integrate advanced nuclear medicine technologies into clinical practice.
Segment Momentum
- Oncology accounted for 49.98% of the market in 2025 and remains the fastest-growing application because SPECT is widely used to assess cancer progression, treatment response, and ongoing patient management.
- Diagnostics imaging centers are expanding fastest as providers and patients increasingly value dedicated outpatient imaging services that offer streamlined scheduling, efficient workflows, and improved access for routine SPECT procedures.
Market Expansion Drivers
- Rising global cancer burden increasing demand for advanced nuclear diagnostic imaging systems.
- Growing adoption of hybrid SPECT/CT systems improving diagnostic precision and clinical efficiency.
- Expanding radiopharmaceutical research strengthening development of specialized molecular imaging applications.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent players in the single-photon emission computed tomography market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Spectrum Dynamics Medical Ltd. (Israel), Mediso Medical Imaging Systems Ltd. (Hungary), MiE GmbH (Germany), Canon Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), TTG Imaging Solutions, LLC (Digirad Corporation) (United States), Rigaku Corporation (MILabs B.V.) (Japan).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As cancer incidence rises, clinicians are relying more heavily on imaging tools that can characterize disease activity, detect metastases, and support treatment planning with greater functional insight than anatomy-only modalities. This is increasing demand for the single-photon emission computed tomography (SPECT) market, particularly in oncology pathways where lesion localization, staging, and therapy monitoring depend on molecular imaging information. Hospitals and diagnostic centers are responding by upgrading nuclear medicine capabilities to handle more complex caseloads, which supports market expansion for SPECT systems that can deliver higher image quality, broader clinical utility, and stronger workflow integration in cancer care.
Growing adoption of hybrid SPECT/CT systems improving diagnostic precision and clinical efficiency
The shift toward hybrid platforms is influencing market adoption by aligning purchasing decisions with the need for both functional and anatomical imaging in a single examination. In the single-photon emission computed tomography (SPECT) market, SPECT/CT systems improve localization accuracy and reduce interpretive uncertainty, which makes them more attractive for institutions seeking clearer diagnostic output and more efficient patient management. That practical value also changes replacement cycles, as providers increasingly favor integrated systems over standalone equipment when modernizing imaging departments, contributing to market size growth through higher-value installations and broader clinical utilization.
Expanding radiopharmaceutical research strengthening development of specialized molecular imaging applications
Progress in radiopharmaceutical development is widening the range of biological processes that can be visualized, which is driving market development for the single-photon emission computed tomography (SPECT) market beyond traditional diagnostic use cases. As new tracers are designed for more specific disease targets, healthcare providers gain stronger justification to use SPECT in applications where functional specificity directly influences clinical decisions. This pipeline effect supports demand for systems capable of accommodating evolving protocols and specialized imaging workflows, while also encouraging manufacturers to position SPECT platforms around disease-focused applications rather than general-purpose nuclear imaging alone.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global cancer burden increasing demand for advanced nuclear diagnostic imaging systems | 1.80% | Moderate | North America, Europe, Asia Pacific | High | Mid Term |
| Growing adoption of hybrid SPECT/CT systems improving diagnostic precision and clinical efficiency | 1.50% | High | North America, Europe | Medium | Mid Term |
| Expanding radiopharmaceutical research strengthening development of specialized molecular imaging applications | 1.20% | High | North America, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 46.56% share of the single-photon emission computed tomography (SPECT) market in 2025, supported by its established nuclear imaging infrastructure, broad installed base of diagnostic systems, and steady utilization across cardiology, oncology, and neurology applications. The region’s leadership is reinforced by mature hospital networks and imaging centers that can integrate SPECT into routine diagnostic workflows, alongside consistent demand for functional imaging in complex disease assessment. This operating environment sustains equipment use, replacement activity, and related service demand across the regional market.
Asia Pacific is projected to expand at a 3.31% CAGR over the forecast period in the single-photon emission computed tomography (SPECT) market, driven by the widening adoption of advanced diagnostic imaging across developing healthcare systems. Growth is being propelled by expanding access to hospital-based imaging, rising use of nuclear medicine in clinical practice, and ongoing investment in diagnostic capacity as patient volumes increase across major regional economies. As healthcare providers broaden imaging availability and incorporate more sophisticated diagnostic pathways, SPECT adoption is gaining momentum in practical, facility-level deployment.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic ImagingGermany emphasizes single-photon emission computed tomography systems that deliver consistent diagnostic performance across specialized medical centers. Investment focuses on advanced imaging capabilities, optimized workflows, and integration with comprehensive nuclear medicine services.
France 🇫🇷
Hospital Imaging OptimizationFrance focuses on optimizing single-photon emission computed tomography services through equipment modernization and standardized diagnostic pathways. Healthcare institutions value systems that improve image consistency while supporting multidisciplinary patient care.
Italy 🇮🇹
Specialized Nuclear MedicineItaly supports the single-photon emission computed tomography market through specialized nuclear medicine departments serving diverse diagnostic needs. Clinical priorities include dependable imaging performance, efficient patient throughput, and compatibility with evolving diagnostic protocols.
Japan 🇯🇵
Clinical Imaging EfficiencyJapan advances the use of single-photon emission computed tomography through healthcare facilities seeking reliable diagnostic imaging with streamlined clinical workflows. The market favors compact, high-performance systems that support routine evaluation of complex medical conditions.
South Korea 🇰🇷
Digital Imaging AdvancementSouth Korea strengthens its single-photon emission computed tomography market by integrating digital imaging technologies into modern hospital environments. Healthcare providers prioritize enhanced image quality, faster examinations, and efficient management of diagnostic procedures.
United States 🇺🇸
Advanced Nuclear ImagingThe U.S. single-photon emission computed tomography market supports growing demand for functional imaging in cardiology, neurology, and oncology. Healthcare providers prioritize imaging systems with improved diagnostic accuracy, workflow efficiency, and compatibility with hybrid imaging technologies.
Segment Leadership and Growth Trends
Single-Photon Emission Computed Tomography (SPECT) Market Share (%), Application Channel, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportOncology accounted for a 49.98% share of the single-photon emission computed tomography (SPECT) market in 2025, making it the leading application channel while also sustaining the strongest growth momentum. Its position is underpinned by the routine use of SPECT in cancer-related imaging workflows where functional assessment helps clinicians evaluate disease spread, treatment response, and follow-up needs. The same clinical reliance is also driving continued expansion, as oncology care pathways increasingly depend on imaging that can support decision-making across diagnosis and management rather than at a single point of care. This keeps oncology firmly at the center of demand in the single-photon emission computed tomography (SPECT) market.
End Use Channel Segment Analysis: Hospitals (Largest Segment) vs Diagnostics Imaging Centers (Fastest-Growing Segment)
Hospitals held a 49.79% share of the single-photon emission computed tomography (SPECT) market in 2025, establishing them as the largest end use channel. Their leadership is maintained through the concentration of integrated clinical services, specialist staffing, and established nuclear medicine infrastructure within hospital settings, which supports consistent SPECT procedure volumes. Hospitals also remain the primary setting for managing complex cases that require coordination between imaging, diagnosis, and treatment planning, reinforcing their share in the single-photon emission computed tomography (SPECT) market.
Diagnostics imaging centers are emerging as the fastest-growing end use channel in the single-photon emission computed tomography (SPECT) market as providers and patients increasingly favor more focused outpatient imaging environments. Their momentum is tied to practical delivery advantages, particularly streamlined scheduling, dedicated imaging workflows, and the ability to handle routine diagnostic demand outside the hospital setting. This makes diagnostics imaging centers increasingly attractive for SPECT utilization where speed, access, and operational efficiency matter more than the broader acute-care capabilities offered by hospitals.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application Channel | Cardiology, Oncology, Neurology, Others | Oncology | Oncology |
| End Use Channel | Hospitals, Diagnostics Imaging Centers, Research & Development Institutes, Others | Hospitals | Diagnostics Imaging Centers |
| Product | Stand-alone SPECT Systems, Hybrid SPECT Systems | Hybrid SPECT Systems | Hybrid SPECT Systems |
Competitive Landscape and Market Positioning
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Spectrum Dynamics Medical Ltd. (Israel)
5. Mediso Medical Imaging Systems Ltd. (Hungary)
6. MiE GmbH (Germany)
7. Canon Medical Systems Corporation (Japan)
8. Shimadzu Corporation (Japan)
9. TTG Imaging Solutions LLC (Digirad Corporation) (United States)
10. Rigaku Corporation (MILabs B.V.) (Japan)
The SPECT market is advancing through improved imaging technologies that enhance diagnostic accuracy and clinical efficiency. Continuous R&D is strengthening imaging resolution and reliability. New system innovations are supporting better clinical outcomes, while collaborative initiatives are improving integration with advanced medical imaging ecosystems.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| GE HealthCare | Apr-25 | GE HealthCare finalized the acquisition of the remaining stake in Nihon Medi-Physics, a developer of radiopharmaceuticals utilized in SPECT and PET imaging. This strategic transaction directly strengthens GE HealthCare’s molecular diagnostics portfolio and broadens its vertical capabilities in regional nuclear medicine imaging markets. |
| GE HealthCare | Jan-24 | GE HealthCare announced an agreement to acquire MIM Software, a provider of medical imaging analysis and artificial intelligence solutions. The acquisition integrates advanced AI software into radiation oncology, diagnostic imaging, and molecular radiotherapy workflows, enhancing GE HealthCare’s technology footprint across distributed healthcare imaging networks. |
| Siemens Healthineers | Jun-22 | Siemens Healthineers launched Symbia Pro.Specta, a high-performance SPECT/CT imaging system that secured concurrent CE mark and FDA clearance. The commercialization of this platform, which features a low-dose 64-slice CT scanner, introduces advanced high-resolution multi-slice diagnostic capabilities to the market. |
| Cancer Centre London | May-24 | Cancer Centre London deployed a state-of-the-art SPECT/CT imaging system supplied by ICON and Nuffield Health. The integration of this dual-modality hybrid hardware materially upgrades the facility's local diagnostic capacity and clinical accuracy for oncology treatment planning. |
| GE HealthCare | Jun-26 | GE HealthCare introduced a suite of AI-enabled imaging software, radiopharmaceuticals, and nuclear medicine hardware solutions. These technologies optimize clinician workflows and advance the scalability of theranostics, supporting broader medical infrastructure adoption of high-performance SPECT imaging applications. |
| The Shrewsbury and Telford NHS Hospital Trust | Aug-24 | The Shrewsbury and Telford NHS Hospital Trust commissioned a new £3.6 million dual-head gamma camera system. This public healthcare capital deployment expands regional clinical capacity and enhances local diagnostic throughput for patients requiring critical SPECT-based molecular imaging procedures. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Single-Photon Emission Computed Tomography (SPECT) Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Single-Photon Emission Computed Tomography (SPECT) Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow big is the single-photon emission computed tomography market?
What is the expected industry size of single-photon emission computed tomography by 2035?
How is oncology demand influencing investment in SPECT imaging systems?
Why are hybrid SPECT/CT systems gaining importance in diagnostic imaging modernization?
Why is oncology the leading application in the single-photon emission computed tomography (SPECT) market?
Why are diagnostics imaging centers the fastest-growing end-use segment in the single-photon emission computed tomography (SPECT) market?
Why is North America the largest SPECT market?
How is Asia Pacific contributing to growth in the SPECT market?
Who are the major participants shaping the single-photon emission computed tomography landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization